- Q2 2024 Eris Lifesciences Ltd Earnings Call TranscriptNov 08, 2023₹897.8 (+3.30%)Earnings
- Q1 2024 Eris Lifesciences Ltd Earnings Call TranscriptAug 07, 2023₹828.2 (+3.45%)Earnings
- Q4 2023 Eris Lifesciences Ltd Earnings Call TranscriptMay 17, 2023₹636.65 (+1.06%)Earnings
- Eris Lifesciences Ltd to Announce Acquisition of Nine Dermatology Brands From Dr Reddy's Laboratories Ltd Call TranscriptMar 16, 2023
- Q3 2023 Eris Lifesciences Ltd Earnings Call TranscriptJan 17, 2023₹651.8 (+0.50%)Earnings
- Q2 2023 Eris Lifesciences Ltd Earnings Call TranscriptOct 20, 2022₹707.85 (-2.92%)Earnings
- Q1 2023 Eris Lifesciences Ltd Earnings Call TranscriptAug 05, 2022₹694.75 (-0.81%)Earnings
- Q4 2022 Eris Lifesciences Ltd Earnings Call TranscriptMay 04, 2022₹663.35 (-1.86%)Earnings
- Q3 2022 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2022₹696.2 (-2.04%)Earnings
- Eris Lifesciences Ltd To Discuss Joint Venture with Mj Biopharm Pvt Ltd Call TranscriptDec 04, 2021
- Q2 2022 Eris Lifesciences Ltd Earnings Call TranscriptOct 29, 2021₹821 (+4.73%)Earnings
- Q1 2022 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2021₹771.15 (+3.91%)Earnings
- Q4 2021 Eris Lifesciences Ltd Earnings Call TranscriptMay 13, 2021₹653.85Earnings
- Q3 2021 Eris Lifesciences Ltd Earnings Call TranscriptJan 28, 2021₹623.1 (+2.03%)Earnings
- Q2 2021 Eris Lifesciences Ltd Earnings Call TranscriptNov 03, 2020₹518.1 (+1.46%)Earnings
- Q1 2021 Eris Lifesciences Ltd Earnings Call TranscriptAug 04, 2020₹510.95 (-5.48%)Earnings
- Q4 2020 Eris Lifesciences Ltd Earnings Call TranscriptJun 02, 2020₹519.2 (-1.59%)Earnings
- Q3 2020 Eris Lifesciences Ltd Earnings Call TranscriptFeb 14, 2020₹465.5 (-11.33%)Earnings
- Q2 2020 Eris Lifesciences Ltd Earnings Call TranscriptNov 07, 2019₹425.55 (+4.61%)Earnings
- Q1 2020 Eris Lifesciences Ltd Earnings Call TranscriptJul 29, 2019₹394.8 (-1.62%)Earnings
- Q4 2019 Eris Lifesciences Ltd Earnings Call TranscriptMay 21, 2019₹605.6 (-1.37%)Earnings
Q1 2022 Eris Lifesciences Ltd Earnings Call Transcript
Ladies and gentlemen, good day, and welcome to the Q1 FY '22 Earnings Conference Call of Eris Lifesciences. (Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. V. Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.
Thank you. Good afternoon, and welcome to our first quarter conference call. I'm Krishnakumar, and I'm happy to share the highlights of this quarter with you. As per AIOCD, the Indian pharma market growth for the quarter was 34% excluding COVID molecules. This growth was led by acute therapies, which have grown at 54% overall and at 44% -- 47% excluding COVID molecules largely on account of the low base of acute in quarter 1 of last year.
I'm happy to share that Eris continues to rank among the top 10 fastest-growing companies based on June MAT data. In fact, Eris is the only company on this list to have a single-digit contribution
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)